Pressley, Maloney Applaud FDA’s Review of Restrictions Preventing Access to Mifepristone

May 8, 2021
Press Release
Announcement Follows Committee Letter Urging Elimination of In-Person Dispensing Requirement

WASHINGTON – Today, Congresswoman Ayanna Pressley (MA-07), Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force, and House Oversight Committee Chairwoman Carolyn B. Maloney, issued the following statement in response to the Food and Drug Administration (FDA) announcing an evidence-based review of the in-person dispensing requirement for the medication abortion drug mifepristone:

“We applaud FDA for taking this necessary step toward policies that are rooted in science.  The harmful and unnecessary in-person dispensing requirement for mifepristone prevents people—particularly those harmed by longstanding health inequities—from receiving safe, effective reproductive health care.  That is why we have consistently called on FDA to permanently lift this requirement.  People deserve comprehensive reproductive health care, and the federal government must make every effort to protect and expand access to safe, legal abortion in the United States.”

On April 13, 2021, FDA announced that it would temporarily lift the in-person dispensing requirement for mifepristone for the duration of the coronavirus public health emergency.  Rep. Pressley and Chairwoman Maloney commended FDA’s decision and urged the agency to permanently eliminate the requirement.

On February 9, 2021, Congresswoman Pressley and Chairwoman Maloney led all Democratic Committee congresswomen in sending a letter asking the FDA to lift the medically unnecessary in-person dispensing requirement for mifepristone—a prescription medication that has been used to safely end early pregnancies in the United States for more than two decades.  

On February 17, 2021, Chairwoman Maloney and Committee Member Pressley published an op-ed in ELLE explaining the urgent need for FDA to lift medically unnecessary restrictions on medication abortion care.  

As Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force, Congresswoman Pressley has fought tirelessly to protect comprehensive reproductive health care for all, including abortion care.

  • Over the course of her first term serving in Congress, Congresswoman Pressley has filed amendments every year to repeal Hyde from annual Labor, Health and Human Services, Education and Related Agencies appropriations bills and in July published a Medium post on the importance of doing so.
  • In April, Rep. Pressley, along with Congresswomen Barbara Lee (CA-13), Diana DeGette (CO-01) and Jan Schakowsky (IL-09), led a group of 131 Democratic members in reintroducing the Equal Access to Abortion Coverage in Health Insurance Act or the EACH Act, which would repeal the Hyde Amendment and ensure that all women, regardless of income, insurance or zip code, can make personal reproductive health care decisions without interference from politicians.
  • In May 2020, she led more than 155 Members of Congress in calling on House Democratic leadership to ensure that any future COVID-19 relief packages rejected Republican efforts to use the public health crisis to diminish abortion access.
  • In May 2019, she led more than 100 colleagues in introducing H.Con.Res.40, a resolution reaffirming the House of Representative’s support for Roe v. Wade. In June 2019, Rep. Pressley introduced H.R. 3296, the Affordability is Access Act, to make oral contraception available without a prescription. 

 

# # #